(Q36425417)

English

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

sickle-cell disease

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Javier Bolaños-Meade

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Ephraim J Fuchs

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Leo Luznik

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sophie M Lanzkron

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Christopher J Gamper

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Richard J Jones

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Robert A Brodsky

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

6 September 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

120

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

22

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

4285-4291

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

High-dose cyclophosphamide for graft-versus-host disease prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Allogeneic hematopoietic stem-cell transplantation for sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Cyclophosphamide and cancer: golden anniversary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Blood and marrow transplantation for sickle cell disease: overcoming barriers to success

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Hematopoietic stem cell transplantation in sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Mixed chimerism: preclinical studies and clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

30 September 2017

Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

28 June 2018

Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

28 June 2018

Desensitization in HLA-incompatible kidney recipients and survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

21 September 2018

Stem-cell transplantation for sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

21 September 2018

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

21 September 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

21 September 2018

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

21 September 2018

Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

21 September 2018

Bone marrow transplantation for sickle cell disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

21 September 2018

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507140

4 December 2018

Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22955919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurologic complications after allogeneic marrow transplantation for sickle cell anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22955919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings

1 reference

https://pubmed.ncbi.nlm.nih.gov/22955919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22955919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2012-07-438408

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36425417&oldid=1642728259"